author(s)
Geethanjali N and Smriti G Solomon

abstract
Cervical cancer is a leading cause of cancer-related fatalities among women in India, primarily resulting from ongoing infections with high-risk types of human papillomavirus (HPV). The persistent nature of these infections underscores the need for a proactive approach to prevention. Vaccination against HPV, particularly in adolescent girls, has demonstrated its effectiveness as a primary prevention method. By preventing the initial infection, the vaccine significantly reduces the risk of cervical cancer, thereby saving countless lives. The vaccine's effectiveness and cost-efficiency make it an ideal solution for preventing cervical cancer. Recent advancements, such as the introduction of locally produced and single-dose vaccines, are expected to enhance accessibility and coverage, ultimately leading to improved health outcomes. However, several challenges persist, including vaccine hesitancy, logistical issues, and a lack of awareness, which must be addressed to ensure the successful implementation of HPV vaccination programs. The Indian government has initiated national initiatives to incorporate HPV vaccination into the Universal Immunisation Programme, with the ultimate goal of achieving widespread protection and making significant progress towards the elimination of cervical cancer.